Electrophoretically transferring electropherograms to nitrocellulose
sheets for immuno-assays
    1.
    发明授权
    Electrophoretically transferring electropherograms to nitrocellulose sheets for immuno-assays 失效
    将电泳图电泳转移到硝酸纤维素片上用于免疫测定

    公开(公告)号:US4452901A

    公开(公告)日:1984-06-05

    申请号:US261217

    申请日:1981-04-20

    摘要: Solid supports for proteins consisting of nitrocellulose sheets containing a replica of an electropherogram of proteins as obtained by electrophoretic separation in a gel. Faithful replica of such electropherograms on the nitrocellulose support can be obtained by contacting the gel with a nitrocellulose sheet and applying an electric field perpendicular to the plane of the gel causing an electrophoretic migration of the proteins toward the nitrocellulose sheet where the proteins are adsorbed. Various analytical problems and especially immuno-assays, for enzyme immuno-assays or such involving radioactively labeled indicators, can be made with the new solid supports.

    摘要翻译: PCT No.PCT / EP80 / 00018 Sec。 371日期1981年4月20日 102(e)日期1981年4月20日PCT提交1980年3月18日PCT公布。 公开号WO81 / 02790 日期:1981年10月1日。由含有通过凝胶电泳分离获得的蛋白质电泳图复制品的硝酸纤维素片组成的蛋白质的固体支持物。 可以通过使凝胶与硝酸纤维素片接触并施加垂直于凝胶平面的电场,使蛋白质电泳迁移到蛋白质被吸附的硝酸纤维素片上,可以获得硝酸纤维素载体上的这种电泳图的忠实复制品。 可以使用新的固体支持物进行各种分析问题,特别是用于酶免疫测定或涉及放射性标记的指示剂的免疫测定。

    Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
    2.
    发明授权
    Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein 失效
    使用人髓磷脂碱性蛋白质的肽类似物治疗多发性硬化症的方法

    公开(公告)号:US06379670B1

    公开(公告)日:2002-04-30

    申请号:US09378244

    申请日:1999-08-19

    IPC分类号: A61K3900

    CPC分类号: C07K14/4713 A61K38/00

    摘要: The present invention is directed toward peptide analogs of human myelin basic protein. The peptide analog is at least seven amino acids long and derived from residues 83 to 99 of human myelin basic protein. The analogs are altered from the native sequence at least at positions 91, 95, or 97. Additional alterations may be made at other positions. Pharmaceutical compositions containing these peptide analogs are provided. The peptide analogs are useful for treating multiple sclerosis.

    摘要翻译: 本发明涉及人髓磷脂碱性蛋白的肽类似物。 肽类似物长至少七个氨基酸,并衍生自人髓磷脂碱性蛋白的残基83至99。 类似物至少在91,95或97位从天然序列改变。可以在其他位置进行其它改变。 提供含有这些肽类似物的药物组合物。 肽类似物可用于治疗多发性硬化。

    Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
    3.
    发明授权
    Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein 失效
    使用人髓磷脂碱性蛋白质的肽类似物治疗多发性硬化症的方法

    公开(公告)号:US06251396B1

    公开(公告)日:2001-06-26

    申请号:US09137759

    申请日:1998-08-20

    IPC分类号: A61K3900

    CPC分类号: C07K14/4713 A61K38/00

    摘要: The present invention is directed toward peptide analogs of human myelin basic protein. The peptide analog is at least seven amino acids long and derived from residues 83 to 99 of human myelin basic protein. The analogs are altered from the native sequence at least at positions 91, 95, or 97. Additional alterations may be made at other positions. Pharmaceutical compositions containing these peptide analogs are provided. The peptide analogs are useful for treating multiple sclerosis.

    摘要翻译: 本发明涉及人髓磷脂碱性蛋白的肽类似物。 肽类似物长至少七个氨基酸,并衍生自人髓磷脂碱性蛋白的残基83至99。 类似物至少在91,95或97位从天然序列改变。可以在其他位置进行其它改变。 提供含有这些肽类似物的药物组合物。 肽类似物可用于治疗多发性硬化。